Useful links

Data transfer

Sprend - useful tool for sending large files over the internet
 
CloudStor - for sharing files of any size. For students, researchers, employees vand others at universities and colleges that uses UNINETT as inetrnet supplyer. Find out if you are eligible here.
 
StoreBioInfo - This portal let you organize your large scale life sciences data projects. A collaboration between NorStore and the Norwegian Bioinformatics platform.

 

Technology providers

Illumina - Next generation sequencing, Microarrays

Agilent - Microarrays, Bioanalyzer.

Affymetrix - Microarrays

Life Technologies - Kits for sample labeling for microarrays, library preparation for Next generation sequencing etc.

 

 
 
 
 
 
 


News

Feb 24, 2016

The HiSeq 4000 build upon the existing HiSeq 2500 platform using the new HiSeq X patterned flow cell technology, providing unparalleled speed and performance. The dual-flow cell HiSeq 4000 System delivers the highest throughput and lowest price per sample across multiple applications. The new sequencer will provide users will faster turnaround time (run time is 3 days compared to 6-11 days in HiSeq 2500) and higher quality, more data per run and longer reads (150 bp paired-end).

Feb 15, 2016

The Oslo University Hospital Genomics and Bioinformatics Core Facilities will relocate to the new Oslo Cancer Cluster Innovation park to colocalise with the section for Molecular Pathology. The colocalisation will facilitate the technology and competence transfer from our genomics environment to accelerate the implementation of high-throughput sequencing for clinical stratification of cancer patients.


Contact Information:

oslo<at>genomics.no 

Visiting address:
Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building 
 
Norwegian Radium Hospital 
Ullernchaussen 66, Lamell 3, 2B 
NO-0379 Oslo, NORWAY

+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office

Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.

................................................................

................................................................